Quotations
Famous Quotations
Sometimes it is difficult to be motivated and inspired to write a review, a persuasive formless essay, an article of reflexive investigation, etc. Plus, it can be difficult to find the right words that will better describe your ideas. DedicatedWriters.com is your top destination, since it provides students with an updated database of more than 150.000 quotations and proverbs of famous inventors, sportsmen, philosophers, artists, celebrities, businessmen, and the authors who certainly enriched and strengthen the world. This is perfect to become inspired and write book reports, essays, movie reviews, research papers, etc.
Try out our free search option and stay tuned.
Catherine Arnold Quotes
«We think the downside risk here is modest. Merck has fundamental challenges ahead based on its base business. We really concluded the stock is trading incorporating these items.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications. It (the U.K. ruling) is a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications, ... It [the U.K. ruling] is a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications, ... a nice psychological boost but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«The U.S. case is more important because of the economic implications. [The U.K. ruling] is a nice psychological boost, but you can't extrapolate the U.S. ruling from this because of the different legal standards.»
Author: Catherine Arnold
«This is half the savings that Pfizer achieved with its recently announced program.»
Author: Catherine Arnold
«After a long product portfolio transition, we forecast that Bristol-Myers could return to a period of sustained high teens earnings per share growth in 2007-2010.»
Author: Catherine Arnold
«We just can't get there. Maybe they see something we don't see.»
Author: Catherine Arnold
«Lilly's current valuation still provides an attractive entry point. The stock trades at a modest 8% to 10% premium to its peers against 2006 and 2007 earnings and at a discount against our 2008 to 2010 forecast.»
Author: Catherine Arnold
«Schering-Plough shares are most likely to be impacted by first quarter 2006 results.»
Author: Catherine Arnold